Skip to main content
. 2010 Jul 6;1(5):196–201. doi: 10.1111/j.2040-1124.2010.00048.x

Table 3.  Effects of treatment regimens on platelet‐derived microparticles.

Baseline Week 24 Week 63
Total (n = 28) 14.2 ± 7.6 9.4 ± 3.2* 10.1 ± 3.8*
Val group (n = 14) 15.5 ± 9.1 9.6 ± 3.8* 10.9 ± 3.9*
Tel group (n = 14) 12.9 ± 5.8 9.2 ± 2.7* 9.3 ± 3.7*

Data are expressed as the mean ± SD (U/mL). Tel, telmisartan; Val, valsartan; ACR, albumin/creatinine excretion ratio; PDMP, platelet‐derived microparticles. *P < 0.05 vs baseline.